The third international consensus definitions for sepsis and septic shock (sepsis-3)

JAMA - Journal of the American Medical Association

Volumn 315, Issue 8, 2016, Pages 801-810

  Singer, Mervyn ^a   Deutschman, Clifford S ^b   Seymour, Christopherwarren ^c   Shankar Hari, Manu ^d   Annane, Djillali ^e   Bauer, Michael ^f   Bellomo, Rinaldo ^g   Bernard, Gordon R ^h   Chiche, Jean Daniel ⁱ   Coopersmith, Craig M ^j   Hotchkiss, Richard S ^k   Levy, Mitchell M ^l   Marshall, John C ^m   Martin, Greg S ^j   Opal, Steven M ^l   Rubenfeld, Gordon D ^n,o   Poll, Tomvan Der ^p   Vincent, Jean Louis ^q   Angus, Derek C ^c,r  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f JENA UNIVERSITY HOSPITAL   (Germany)

^g MONASH UNIVERSITY   (Australia)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Cochin Institute ^*  (France)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BROWN UNIVERSITY   (United States)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^o UNIVERSITY OF TORONTO   (Canada)

^p ACADEMIC MEDICAL CENTER   (Netherlands)

^q ERASME HOSPITAL   (Belgium)

^r JAMA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN; CREATININE; LACTIC ACID; BIOLOGICAL MARKER; LACTIC ACID DERIVATIVE; VASOCONSTRICTOR AGENT;

AREA UNDER THE CURVE; BREATHING RATE; CELL DAMAGE; CLINICAL EVALUATION; CONSENSUS; DATA BASE; ELECTRONIC MEDICAL RECORD; FLUID RESUSCITATION; GLASGOW COMA SCALE; HIGH RISK PATIENT; HUMAN; HYPERLACTATEMIA; HYPOVOLEMIA; ICD-10; INCIDENCE; INFECTION; INFECTION RISK; INTENSIVE CARE; LACTATE BLOOD LEVEL; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; MORTALITY; MORTALITY RATE; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN TENSION; PATHOLOGY; PEER REVIEW; PRACTICE GUIDELINE; PRESSOR RESPONSE; PRIORITY JOURNAL; QUICK SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; RATING SCALE; REVIEW; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; VALIDITY; ADVISORY COMMITTEE; BLOOD; BLOOD PRESSURE; CLASSIFICATION; COMPLICATION; CONSENSUS DEVELOPMENT; DELPHI STUDY; DRUG EFFECTS; INTERNATIONAL CLASSIFICATION OF DISEASES; NOMENCLATURE; ORGAN DYSFUNCTION SCORE; ORGANIZATION AND MANAGEMENT; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC;

ADVISORY COMMITTEES; BIOMARKERS; BLOOD PRESSURE; DELPHI TECHNIQUE; HOSPITAL MORTALITY; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LACTATES; ORGAN DYSFUNCTION SCORES; PEER REVIEW, RESEARCH; RESPIRATORY RATE; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERMINOLOGY AS TOPIC; VASOCONSTRICTOR AGENTS;

EID: 84959273475     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.0287     Document Type: Review

References (36)

1. Torio CM, Andrews RM. National inpatient hospital costs: the most expensive conditions by payer, 2011. Statistical Brief# 160. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. August 2013. http://www.ncbi.nlm.nih.gov/books/NBK169005/. Accessed October 31, 2015.
2. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J AmGeriatr Soc. 2012;60(6):1070-1077.
3. Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167-1174.
4. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580-637.
5. Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care-reasons for caution. N Engl J Med. 2014;370(18):1673-1676.
6. Vincent J-L, Marshall JC, Namendys-Silva SA, et al; ICON Investigators. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2(5):380-386.
7. Fleischmann C, Scherag A, Adhikari NK, et al; International Forum of Acute Care Trialists. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations. Am J Respir Crit Care Med. 2015.
8. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787-1794.
9. Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-874.
10. Levy MM, Fink MP, Marshall JC, et al; International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530-538.
11. Vincent J-L, Opal SM, Marshall JC, Tracey KJ. Sepsis definitions: time for change. Lancet. 2013;381(9868):774-775.
12. Seymour CW, Liu V, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis. JAMA. doi: 10.1001/jama.2016.0288.
13. Shankar-Hari M, Phillips G, Levy ML, et al Assessment of definition and clinical criteria for septic shock. JAMA. doi:10.1001/jama.2016.0289
14. Angus DC, Van Der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-851.
15. Wiersinga WJ, Leopold SJ, Cranendonk DR, Van Der Poll T. Host innate immune responses to sepsis. Virulence. 2014;5(1):36-44.
16. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862-874.
17. Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40(4):463-475.
18. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrinemediated, metabolic response to overwhelming systemic inflammation. Lancet. 2004;364(9433):545-548.
19. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27(7):1230-1251.
20. Kwan A, Hubank M, Rashid A, Klein N, Peters MJ. Transcriptional instability during evolving sepsismay limit biomarker based risk stratification. PLoS One. 2013;8(3):e60501.
21. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013;93(3):1247-1288.
22. Wong HR, Cvijanovich NZ, Anas N, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med. 2015;191(3):309-315.
23. Langley RJ, Tsalik EL, Van Velkinburgh JC, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5(195):195ra95.
24. Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012;122(8):2711-2719.
25. Churpek MM, Zadravecz FJ, Winslow C, Howell MD, Edelson DP. Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med. 2015;192(8):958-964.
26. Kaukonen K-M, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372(17):1629-1638.
27. Vincent JL, Moreno R, Takala J, et al; Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707-710.
28. Vincent JL, De Mendonça A, Cantraine F, et al; Working Group on "Sepsis-Related Problems" of the European Society of Intensive Care Medicine. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med. 1998;26(11):1793-1800.
29. Rubulotta FM, Ramsay G, Parker MM, Dellinger RP, Levy MM, Poeze M; Surviving Sepsis Campaign Steering Committee; European Society of Intensive Care Medicine; Society of Critical Care Medicine. An international survey: public awareness and perception of sepsis. Crit Care Med. 2009;37(1):167-170.
30. Le Gall J-R, Klar J, Lemeshow S, et al; ICU Scoring Group. The Logistic Organ Dysfunction system: a new way to assess organ dysfunction in the intensive care unit. JAMA. 1996;276(10):802-810.
31. Shah RU, Henry TD, Rutten-Ramos S, Garberich RF, Tighiouart M, Bairey Merz CN. Increasing percutaneous coronary interventions for ST-segment elevationmyocardial infarction in the United States: progress and opportunity. JACC Cardiovasc Interv. 2015;8(1 pt B):139-146.
32. Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371(24):2309-2319.
33. Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med. 2015;43(3):567-573.
34. Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task Force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795-1815.
35. Czura CJ. "Merinoff symposium 2010: sepsis"-speaking with one voice. Mol Med. 2011;17(1-2):2-3.
36. Ait-Oufella H, Bige N, Boelle PY, et al. Capillary refill time exploration during septic shock. Intensive Care Med. 2014;40(7):958-964.